| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.44▲ | 2.46▼ | 2.46▼ | 2.53▼ | 2.62▼ |
| MA10 | 2.45▲ | 2.47▼ | 2.47▼ | 2.62▼ | 2.51▼ |
| MA20 | 2.46▼ | 2.48▼ | 2.50▼ | 2.64▼ | 2.59▼ |
| MA50 | 2.47▼ | 2.54▼ | 2.61▼ | 2.54▼ | 2.62▼ |
| MA100 | 2.48▼ | 2.63▼ | 2.66▼ | 2.57▼ | 4.23▼ |
| MA200 | 2.55▼ | 2.66▼ | 2.61▼ | 2.49▼ | 10.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | 0.002▲ | -0.032▼ | 0.010▲ |
| RSI | 47.288▼ | 35.162▼ | 34.698▼ | 42.520▼ | 46.194▼ |
| STOCH | 22.222 | 17.361▼ | 19.660▼ | 15.062▼ | 39.829 |
| WILL %R | -16.667▲ | -68.750 | -75.000 | -94.039▼ | -76.587▼ |
| CCI | -32.083 | -133.786▼ | -159.709▼ | -156.411▼ | -30.165 |
|
Tuesday, September 08, 2026 01:17 AM
New positive preclinical studies show that sabizabulin can overcome drug resistance to daraxonrasib with potent anticancer efficacy ...
|
|
Tuesday, July 14, 2026 01:00 AM
Looking for more tickers? Browse the full market events calendar. Veru (VERU) has scheduled or reported the following types of corporate events: Summit, Corporate Conference Presentation, Shareholders ...
|
|
Thursday, June 04, 2026 07:22 AM
Veru Inc. (NASDAQ:VERU) has entered into a clinical supply agreement with Novo Nordisk A/S (NYSE:NVO) to support its upcoming Phase 2b PLATEAU study, which will investigate a combination treatment for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/09/26 | 2.51 | 2.51 | 2.43 | 2.455 | 235,418 |
| 10/09/26 | 2.52 | 2.53 | 2.46 | 2.50 | 178,369 |
| 09/09/26 | 2.59 | 2.59 | 2.48 | 2.48 | 264,785 |
| 08/09/26 | 2.81 | 2.8494 | 2.55 | 2.58 | 1,329,851 |
| 04/09/26 | 2.65 | 2.73 | 2.63 | 2.64 | 142,836 |
| 03/09/26 | 2.75 | 2.7657 | 2.645 | 2.65 | 75,387 |
| 02/09/26 | 2.70 | 2.76 | 2.65 | 2.75 | 202,580 |
| 01/09/26 | 2.80 | 2.82 | 2.685 | 2.69 | 202,991 |
| 31/08/26 | 2.63 | 2.825 | 2.59 | 2.80 | 250,028 |
| 28/08/26 | 2.71 | 2.73 | 2.61 | 2.625 | 91,055 |
|
|
||||
|
|
||||
|
|